Navigation Links
Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
Date:5/7/2008

TORONTO, May 7 /PRNewswire/ - Apotex Inc., Canada's largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug "Apo Triavir". Apotex is the first company to provide this medicine to Africa under the provisions of the Canadian Access to Medicines Regime (CAMR).

The CAMR provides a mechanism for developing countries to address critical healthcare needs by importing less expensive generic versions of patented drugs. Following the process it has taken Apotex over three years to get to this point where a drug can go to thousands in Africa.

Apotex is the only company in Canada to have worked through the complicated CAMR process. The Generic Pharmaceutical Industry has recommended that the Federal Government simplify the process of getting urgently needed drugs to Africa.

Apo Triavir is a combination of 300 mg Zidovudine, 150 mg Lamivudine and 200 mg Nevirapine and was evaluated and approved under the provision of the CAMR by Health Canada. TriAvir fully conforms to all Health Canada regulations and requirements for marketing a drug in the Canadian healthcare system. As per Canadian regulations, the product can only be exported to eligible countries under CAMR and cannot be sold in Canada until the relevant patents expire.

Apotex is producing Apo Triavir at cost, with the price quoted in the Tender at 19.5 cents (US) per tablet. The three separate AIDS brand products would cost around $6.00 per dose if bought individually.

"If other critical medicines are to go to Africa in a reasonable timeframe, the Federal Government must change the CAMR Legislation. CAMR is unworkable as it now stands. Apotex decided to do this because it was the right thing to do for the people dying from AIDS in Africa," stated Jack Kay, Apotex President and COO.

The Apotex Group has 6,000 employees in Canada and exports close to 300 quality lower cost medicines to 115 countries. It is the # 1 pharmaceutical company in Canada for R&D with planned expenditures of $2 Billion over the next 10 years.


'/>"/>
SOURCE Apotex Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Obesity, inactivity as common among cancer survivors as rest of Canadians, study shows
2. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
3. MIRARCO, Canadian Light Source agreement lights way to greener mining
4. Leading Travel Insurance Website Now Offers Mexican Auto Insurance to US and Canadian Travelers Going into Mexico
5. Baby Bottles Leach Toxic Chemical, According to New U.S. and Canadian Study
6. Mayo Clinic Seeks Mitigation for Rochester as Condition of Canadian Pacific - DM&E Railroad Merger
7. Canadian Marketing and Sales Effort for Labopharms Once-Daily Tramadol Product to Expand Significantly
8. Map the Canadian Healthcare IT Market with the New HIMSS Analytics Canadian Database(SM)
9. Canadian Pacific and Mayo Clinic Build Understanding and Commit to Ongoing Dialogue
10. Mayo Clinic Calls for Thorough Review of Canadian Pacifics Acquisition of the Dakota, Minnesota & Eastern Railroad
11. Canadians welcome HPV vaccine -- but not at any price
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...  Collagen Matrix, Inc., ("Collagen Matrix") the driving ... collagen and mineral based medical devices for tissue ... Messer has joined the company as Vice ... growing portfolio of oral surgery, neurosurgery, orthopaedic and ... the Collagen Matrix executive team as an accomplished ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... -- Research and Markets has announced ... Applications, Technologies, Forecasts" report to their offering. ... Smart Skin, Structural Health Monitoring, Composite Smart Structures, ... involves electronic and/or electrical components and circuits that ... such as vehicle bodies or conformally placed upon ...
Breaking Medicine Technology: